News & Updates

Treatment with non-enteric-coated pancreatic enzyme replacement therapy (NEPERT) does not appear to relieve pain in patients with chronic pancreatitis, according to a study.

Treatment with the anti-epidermal growth factor receptor antibody-drug conjugate becotatug vedotin, compared with chemotherapy, results in significant improvements in objective response rate (ORR) and progression-free survival (PFS) among patients with heavily pretreated and immunotherapy-exposed recurrent or metastatic nasopharyngeal carcinoma (NPC), according to a study.

Rozanolixizumab shows no evidence of benefit in patients with severe fibromyalgia in a phase IIa study.

Singapore’s ageing population and growing burden of chronic disease are seen to propel the prevalence of polypharmacy, which has been shown to be significantly associated with age and type of care setting, according to a study.

Camrelizumab combination therapy demonstrates potential benefits in the treatment of patients with triple-negative breast cancer (TNBC), suggests a study.

Several patients with advanced upper gastrointestinal (UGI) cancer do not receive treatment, reveals a study in an urban safety-net population.

Patients with breast cancer experience clinically relevant fatigue for up to 2 years after treatment initiation, according to a study.